Search results for "peptide"

Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group

Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group

Samsung Biologics is proceeding with a 3 trillion won ($2.25 billion) rights offering, directing approximately 90% of the proceeds toward acquiring...
Can Eggs and Olive Oil Help You Lose Weight? Why the

Can Eggs and Olive Oil Help You Lose Weight? Why the "Natural Wegovy" Trend Can Backfire

A viral diet trend touting olive oil drizzled over boiled eggs as a "natural Wegovy" has gained traction among individuals seeking rapid weight loss.
Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells

Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells

South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific...
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan.
Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports

Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports

GLP-1 (glucagon-like peptide-1) class medications, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, are...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
'Natural Wegovy' Is a Myth, Surgeon Warns, Pushing Back on Viral Diet Trend

'Natural Wegovy' Is a Myth, Surgeon Warns, Pushing Back on Viral Diet Trend

A viral social media trend promoting a "Natural Wegovy" diet—eating boiled eggs drizzled with olive oil—has prompted a...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short

Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.
Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market

Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market

The glucagon-like peptide-1 (GLP-1) obesity treatment market, long dominated by subcutaneous injections, is rapidly...